U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. About FDA
  3. FDA Organization
  4. Office of the Commissioner
  5. Office of the Chief Scientist
  6. National Center for Toxicological Research
  7. Science & Research (NCTR)
  8. NCTR Research Focus Areas
  9. Nanotechnology
  1. NCTR Research Focus Areas
Nanotechnology: Over a Decade of Progress and Innovation at FDA
Presented by Anil Patri, Ph.D.

Watch the Recorded Presentation

 

Nanotechnology Research at NCTR

Nanotechnology, the manipulation of material at nanoscale dimensions is a challenging scientific area where specific tools are needed to characterize and detect the nanoscale materials. Recent advances have allowed scientists the ability to visualize, manipulate, and control matter of this size and use it in the development of novel drug products, and vaccines. The FDA has already reviewed and approved many nanotechnology-based products, and expects a significant increase in the use of nanoscale materials in medical products. NCTR scientists are conducting research on: 

  • Material characterization and detection methods for capacity-building of scientists and reviewers
  • International standards development 
  • In vitro and in vivo studies on emerging and generic drug products 
  • Effects on microbiota and microbiome
  • Safety and efficacy of nanocrystalline drug products
  • Immunotoxicity and genetic toxicology of nanomaterials

The NCTR Nanotechnology Core Facility (Nanocore) is located at the FDA’s Jefferson Arkansas Laboratories and is equipped with instrumentation and laboratories with a goal to meet the needs of FDA to understand the toxicity and biological impact of nanoscale materials. 
 

FDA Nanotechnology Resources

External Nanotechnology Resources

  • Note: If you experience difficulties accessing any of the presentations, please copy and paste it into another web browser (Adobe Flash Player must be current for Adobe Connect). 
  • Please contact NCTRComms@fda.hhs.gov if you need assistance with accessibility or have technical issues. 

Subscribe to NCTR Research Highlights Newsletter

Get regular FDA email updates delivered on this topic to your inbox.

Back to Top